Literature DB >> 18216570

Comparison of deep lamellar endothelial keratoplasty and penetrating keratoplasty in patients with Fuchs endothelial dystrophy.

David G Heidemann1, Steven P Dunn, Christopher Y C Chow.   

Abstract

PURPOSE: To evaluate and compare 1-year postoperative visual acuity, refractive results, endothelial cell density (ECD), and complications in a consecutive group of patients who underwent deep lamellar endothelial keratoplasty (DLEK) with those who underwent penetrating keratoplasty (PK) performed by 1 surgeon.
METHODS: We prospectively analyzed results of 20 consecutive patients with Fuchs dystrophy and pseudophakia who underwent small-incision DLEK surgery and retrospectively compared these results with those of 23 consecutive patients with Fuchs dystrophy and pseudophakia who underwent standard PK surgery during the same period. Main outcome measurements were best spectacle-corrected visual acuity (BSCVA); refractive, keratometric, and topographic astigmatism; topographic irregular astigmatism; absolute change in spherical equivalent; and ECD. Postoperative complications in the 2 groups were also analyzed.
RESULTS: Preoperative BSCVA was significantly better in the DLEK group than the PK group (P = 0.013). Postoperative BSCVA was significantly better in the DLEK group than the PK group at 6 months (P = 0.025) and similar in each group at 12 months. Twelve-month postoperative refractive, keratometric, and topographic astigmatism was significantly less in the DLEK group than the PK group (P < 0.001). Surface asymmetry index and change in keratometric spherical equivalent was significantly less in the DLEK group than the PK group at 12 months postoperatively (P < 0.001). Preoperative ECD was significantly higher in the DLEK group (3072 +/- 307 cells/mm) than the PK group (2779 +/- 413 cells/mm). Twelve-month postoperative ECD was similar in the DLEK group (1293 +/- 469 cells/mm) compared with the PK group (1303 +/- 454 cells/mm; P = 0.949, not significant). Twelve-month percent endothelial cell loss was higher than reported in previous studies but was similar in the DLEK group (57.9%) compared with the PK group (53.1%). Twelve months postoperatively, all grafts were clear in the DLEK and PK groups.
CONCLUSIONS: DLEK surgery resulted in more rapid vision recovery, significantly less regular and irregular astigmatism, and less change in spherical equivalent than PK surgery. Endothelial cell loss was significant in both groups but was not significantly different in the DLEK group from the PK group. DLEK surgery has significant advantages over PK surgery, but long-term ECD and graft survival in DLEK surgery should be studied.

Entities:  

Mesh:

Year:  2008        PMID: 18216570     DOI: 10.1097/ICO.0b013e31815b8304

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Fuchs' corneal dystrophy.

Authors:  Allen O Eghrari; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2010-04

Review 2.  Corneal blindness and xenotransplantation.

Authors:  Vladimir Lamm; Hidetaka Hara; Alex Mammen; Deepinder Dhaliwal; David K C Cooper
Journal:  Xenotransplantation       Date:  2014-02-21       Impact factor: 3.907

3.  Histological evaluation of corneal scar formation in pseudophakic bullous keratopathy.

Authors:  Ting Liu; Yuanyuan Xu; Dapeng Sun; Lixin Xie
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 4.  Graft rejection rate and graft failure rate of penetrating keratoplasty (PKP) vs lamellar procedures: a systematic review.

Authors:  Zarique Z Akanda; Abdul Naeem; Elizabeth Russell; Jillian Belrose; Francie F Si; William G Hodge
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

5.  Descemet stripping and endothelial keratoplasty in endothelial dysfunctions: three-month results in 75 eyes.

Authors:  Samar K Basak
Journal:  Indian J Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.848

Review 6.  Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy.

Authors:  Mayank A Nanavaty; Xue Wang; Alex J Shortt
Journal:  Cochrane Database Syst Rev       Date:  2014-02-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.